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Abstract
This study has determined the natural frequency and localization of progenitor/stem cells within fat
depots in situ based on their ability to retain DNA nucleotide label (BrdU). Neonate and mature male
C57BL6/J mice were injected intraperitoneally with BrdU- and label-retaining cells (LRC) were
quantified in fat depots by immunohistochemical, immunofluorescent, and flow cytometric methods.
In neonates, LRC constituted 27% of the cells in inguinal fat (iWAT) and 65% in interscapular brown
fat (BAT) after Day 10 and 26% of the cells in epididymal fat (eWAT) after Day 28. After 52 days,
the LRC accounted for 0.72% of iWAT, 0.53% of eWAT and 1.05% of BAT, respectively. The
BrdU-labeled cells localized to two areas: single cells distributed among adipocytes or those adjacent
to the blood vessels wall. In mature C57BL6/J mice, flow cytometric analysis determined that a
majority of the LRC were also positive for stem cell antigen-1 (Sca-1).
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Weight gain associated with obesity is characterized by an increase in adipose mass that is
achieved by two processes: hypertrophy of existing fat cells and hyperplasia throughout
generation of new adipocytes from the pool of tissue resident stem cells. Hypertrophy of
adipocytes through a positive energy balance has been well documented in humans and animal
models [1]. While some studies have suggested that WAT expansion during adulthood also
results from an increased number of adipocytes [2,3], other studies point out that the number
of fat cells stays constant in both lean and obese adults as recently shown for human adipose
tissues [4]. A platform where this controversy meets is in vitro vs. in vivo studies. The
tremendous progress in in vitro techniques allows for the isolation and culture of stem cells/
progenitor cells from adult tissues and the ability of adult stem cells to differentiate into several
lineages, to display clonogenic potentials, and to express transcriptional factors related to their
undifferentiated/pluripotent stage has been well documented [5–8]. Although many features
of the molecular properties of these adult stem cells have been described, a well-defined
signature for their presence is still missing [1].
© 2008 Elsevier Inc. All rights reserved.
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The lack of precise molecular markers for adult stem cells is a limiting factor of in vivo studies
and in vivo methodologies that aim to overcome this obstacle are based on the slow-cell cycling
feature of stem cells [9–14]. The principle of the method posits that in vivo labeling through
incorporation of [3H]thymidine or 5-bromo-2′-deoxyuridine (BrdU) into cells’ DNA during
the early postnatal development allows for the detection of slow-cycling/stem cells through
the retention of the label in adult animals. This approach has been successfully used to identify
label-retaining cells (LRC)/stem cells in epithelial compartment as in skin [12], bladder [10],
colon [14], and endometrium [11], and in some of the mesenchymal compartments:
myometrium [13] and kidney [9].
Adipose tissues contain a population of adult/somatic stem cells that have been isolated from
human and animals [5,15]. These cells, termed adipose-derived stem or stromal cells (ASC),
are self renewing and can differentiate along several mesenchymal tissues lineages including
adipocytes, osteoblasts, myocytes, chondrocytes, endothelial cells, and neurocytes. Whereas
ASC are very well characterized in vitro, there is little knowledge of their natural distribution
and localization within fat tissues in vivo. Elegant studies performed by Hirsh and co-workers
in the 1970s and early 1980 [2,16] detected a small population of cells residing in the stromal-
vascular fraction of adipose tissues that can take up [3H]thymidine. The authors concluded that
these cells “may be an adipocyte progenitor or may have some other unknown
function” [16]. Following in the footsteps of Hirsh's studies, the current article describes the
in vivo localization and characteristics of LRC in adipose tissues. We demonstrate the existence
of LRC/stem cells in fat depots that are localized to two compartments: those close to the blood
vessels wall and those sparsely distributed among adipocytes. Moreover, we show that BrdU-
retaining cells are stem cell antigen-1 (Sca-1) positive and hematopoietic lineage (CD45/CD4)
negative. These findings confirm and extend our previous studies showing that Sca-1 is a
biomarker for ear mesenchymal stem cells (EMSC) with adipogenic potential [17].
Materials and methods
Experimental animals and BrdU labeling
All experiments involving animals were approved by the Pennington Biomedical Research
Center Institutional Animal Care and Use Committee in accordance with NIH guidelines. We
used the BrdU labeling approach to label and then identify/quantify LRC in fat depots. In the
first experiment neonate, 3.5-day-old male C57BL/6J mice (n = 10) were injected
intraperitoneally with BrdU at a concentration of 50 μg/g of body weight (Sigma Co., St. Louis,
MO) twice daily, at 7.00 am and 6.00 pm for 3 consecutive days (total 7 injections). Control
animals (littermates; n = 5) were injected with saline. Chase periods for BrdU-labeled fat tissues
were 10, 28 or 39, and 52 days. Tissues were harvested and analyzed for BrdU containing
nuclei by immunohistochemistry and immunofluorescence.
The second experiment was performed on adult animals and involved the flow cytometric
detection of BrdU-retaining cells in the stromal-vascular fraction of fat depots and in bone
marrow (BM) cells. Male 4-month-old C57BL/6J mice were intraperitoneally injected with
BrdU (n = 6) or saline (control n = 4). The BrdU dose and schedule of injections were the same
as in the first experiment. Animals were euthanized 24 h (n = 6) after the last injection of BrdU.
Epididymal and inguinal fat depots were collected, minced, and digested with collagenase class
I (2 mg/ml; Worthington Biochemical Corp., Freehold, NJ). Bone marrow cells were collected
from tibia and femurs. Cells were suspended in red blood cell lysing buffer (Sigma Co., St.
Louis, MO) to remove erythrocyte contamination before analyzing by flow cytometry.
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Histological detection of BrdU-labeled cells
Euthanized animals were perfused with PBS via cardiac puncture followed by 4%
paraformaldehyde. Dissected fat depots were embedded in paraffin and sectioned at 5 μm.
Immunohistochemistry
To denaturate DNA dewaxed sections were treated with 1 N HCl at room temperature for 10
min, then with 2 N HCl at 37 °C for 20 min followed by incubation in 0.1 M borate buffer.
Primary anti-BrdU antibody (rat anti-mouse ab6326 Abcam) at a concentration of 1:400 was
applied overnight at 4 °C.
For immunohistological antibody binding detection ABC complex was applied (Vectastain
ABC kit, Vector Laboratories, Inc., Burlingame, CA). Two types of controls were performed:
(a) the primary antibody was substituted with non-specific immunoglobulin G (IgG) during
the procedure, and (b) fat depot sections from saline treated animals were subjected to BrdU
detection. Samples were counterstained with hematoxylin. Sections were visualized with a
Zeiss microscope (Axioskop 40) using Plan-Neofluor 10× objective and photographed with a
Kodak digital camera (DC290 Zoom). Quantitative analyses of immunopositive cells were
made using Metamorph software. For LRC quantitation, adipocytes and BrdU-positive cells
were counted from 5-fields and the label-retaining cells expressed as a percentage of total
adipocytes counted. BrdU-retaining cells in brown fat tissues were expressed as a percentage
of total nuclei counted.
For immunofluorescence detection of BrdU-labeled cells goat anti-rat antibodies conjugated
to Alexa Fluor 488 (Molecular Probes, Eugene, OR) followed overnight incubation with
primary anti-BrdU antibody were applied. BrdU expression was imaged using an Everest
imaging system (Intelligent Imaging Innovation, Inc., Denver, CO) based on a Zeiss Meta 510
confocal microscope.
BrdU flow cytometry assay
Cells from the stromal-vascular fraction of fat depots or BM were first incubated with
phycoerythrin (PE) conjugated anti-Sca-1 antibodies (BD Pharmingen San Diego, CA).
Similar cells suspensions were incubated with PE conjugated anti-CD45 and anti-CD4
antibodies (BD Pharmingen San Diego, CA). Next cells were fixed, treated with DNase to
expose BrdU epitopes, and incubated with FITC-conjugated anti-BrdU antibodies following
instruction of the manual (FITC BrdU Flow Kit BD Pharmingen San Diego, CA). The flow
cytometry assay was performed using a FACScan flow cytometer (Becton Dickinson, San Jose,
CA) and data were analyzed with a Macintosh G5 workstation (Apple Computer, Cupertino,
CA), which contains Cellquest graphics software (Becton Dickinson, San Jose, CA) for data
acquisition and analysis. Gates were always set using cells isolated from animals that received
injections of saline instead of BrdU, but the samples were processed and stained alongside the
experimental samples. The data were expressed as a percent of BrdU, Sca-1, and CD4/CD45
positive cells per gated cells. FACS plots and data are representative of three separate
experiments.
Results
BrdU-retaining cells during postnatal fat depots development
In our first experiment, we administered BrdU to 3.5-day-old mice for a period of 3 days. The
fat depots were collected at Day 10, 28 or 39, and 52. In the mouse, adipose tissue is formed
post-natally; subcutaneous iWAT first appears at about 1 day of age, while the visceral white
fat depots appear at about 9 days of age [1,18]. On the other hand, BAT development starts
during late gestation with developmental reaching a peak at Day 10 after birth [1,18]. Therefore,
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we collected BAT and inguinal white adipose tissues (iWAT) at Day 10 of postnatal life. At
Day 28, 39, and 52 we collected BAT, iWAT, and epididymal white adipose tissues (eWAT).
Interscapular brown adipose tissue
At Day 10 of development quantitative analysis of BAT histological sections revealed that
65.76% ± 25.9% of total nuclei are positive for BrdU (Fig. 1A and I). To confirm that BrdU
incorporation is localized to the nucleus we performed double-immunofluorescence staining
using FITC-conjugated anti-BrdU antibodies together with DAPI staining (Fig. 1L). As
expected, BrdU staining co-localized with DAPI stained nuclei (Fig. 1L). Immunofluorescent
and immunohistochemical analyses showed that LRC were uniformly distributed through BAT
(Fig. 1A and L). On Day 28 the number of BrdU-positive cells had decreased to 22.8% ± 2.3%
(Fig. 1B and I), although the LRC distribution and intensity of staining were similar to that on
Day 10. A significant decrease in number of cells positive for BrdU was observed at Day 52
(Fig. 1C and I) when 1.05% ± 0.6% of cells still retained intense staining for incorporated
BrdU.
Inguinal white adipose tissue
To quantify the number of BrdU-retaining cells in white fat depots, we expressed them as a
percentage of the number of adipocytes. iWAT at Day 10 contained 27.43% ± 2.86% of cells
that were positive for BrdU (Fig. 1D, J, and M). Further analysis of immunohistologically
stained sections from Days 39 and 52 of development showed a significant decrease in BrdU-
retaining cells. We determined that between 1–5 cells per field at Day 39 (2.83% ± 2.3%) and
0–2 (0.72% ± 0.62%) at Day 52 cells per field were BrdU-positive (Fig. 1E, F, and J).
Epididymal white fat depot
Analysis of epididymal fat tissues of 28-day-old animals revealed that 24 days after the final
IP injection of label, 26.09% ± 4.12% of adipocytes are BrdU-positive (Fig. 1G and K).
However, the number of BrdU-stained cells fell to 0.53% ± 1.1% at Day 52, the lowest
frequency among the studied fat depots (Fig. 1H and K).
Although we observed differences in the density and the rate of decline of BrdU-positive cells
among BAT, iWAT, and eWAT, the distribution of LRC was surprisingly similar irrespective
of the fat depot examined. BrdU-positive cells were found in two areas: single positive cells
distributed among adipocytes and those closely adjacent to the blood vessels wall (Fig. 2). This
pattern of distribution was observed regardless the time point of fat depots collection 10, 39
or 52 (Fig. 2). Fig. 2 shows sections of inguinal fat depots collected at Day 10 (Fig. 2A), 39
(Fig. 2B), and 52 (Fig. 2C) and white adipose tissues surrounded BAT at Day 52 (Fig. 2D).
BrdU-positive cells located in blood vessels regions appeared to be distributed along the outer
wall of blood vessels. This pattern was observed in both longitudinal (Fig. 2D) and horizontal
(Fig. 2B and 2C) sections of blood vessels within fat depots.
BrdU-retaining cells in adult fat depots
Our second approach was to use flow cytometry to identify a stem cell marker in BrdU-labeled
cells in stromal-vascular fractions of fat depots. We first set up gating parameters that allowed
us to distinguish between BrdU-labeled and non-labeled cells in experimental animals by using
cells isolated from control animals (saline treated) that were processed and stained alongside
the experimental samples (Fig. 3D–F). Next, we analyzed cells collected from BrdU-treated
animals considering as BrdU-positive those cells which displayed fluorescent intensity greater
than 99% of that displayed by cells isolated from control animals (compare, Fig. 3A and D; B
and E; and C and F). The analysis showed that BrdU incorporation in eWAT and iWAT fat
depots was 4 and 13 (respectively) times lower than in the bone marrow (Table 1). The LRC
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represented 1.7% of the stromal-vascular fraction of iWAT and 6.04% of eWAT, respectively,
whereas more than 22% of BM cells were BrdU-positive (Table 1). Simultaneously, double-
labeled flow cytometric analysis was performed to evaluate stem cell antigen-1 (Sca-1), in
correlation with BrdU-labeling. A representative cytofluorometric analysis of cells double-
stained with antibodies directed to Sca-1 and BrdU is shown in Fig. 3. More than half of BrdU-
labeled cells of stromal-vascular fraction of iWAT (0.915 ± 0.05% out of 1.7 ± 0.23%) and
eWAT (3.13% ± 1.77% out of 6.04% ± 1.7%) exhibit Sca-1 expression, whereas only a small
proportion (1.68% ± 0.06% out of 22.46% ± 3.9%) of BM cells showed Sca-1 positivity (Table
1). Additionally, in similar cell populations we analyzed cells for the expression of
hematopoietic lineage markers (CD45/CD4) and BrdU-positivity. Double staining for CD45/
CD4 and BrdU detected 1.27% ± 0.43% of inguinal and 4.07% ± 0.62% of epididymal cell
fractions (Table 1). In contrast, of the 79.71% ± 1.02% of BM CD45/CD4 positive cells,
15.53% ± 2.9% expressed BrdU in their nuclei.
Discussion
Using BrdU-labeling methodology followed by immunohistochemical, immunofluorescent,
and flow cytometric analyses, we demonstrate the following: (1) LRC are detected in iWAT,
eWAT and BAT up to 52 days of age, (2) LRC are found in two areas—single positive cells
distributed among adipocytes and those closely adjacent to the blood vessels wall, and (3) the
expression of the stem cell associated surface antigen, Sca-1, co-localizes with LRC.
To our knowledge this study is the first attempt to label cells within fat tissues with BrdU at a
very early postnatal life and follow the retention of the labeled cells into adulthood. The seven
sequential BrdU-injections into 3-day-old animals resulted in the labeling of 27% of iWAT,
65% of BAT (at Day 10), and 26% (at Day 28) of eWAT cells. Studies of others showed initially
higher percentages of BrdU-labeled cells in the epithelial compartment of colon—77% [14],
endometrium—72% [11], and bladder—90% [10]. It is possible that the difference between
our studies and those of others can be attributed to the slower turnover of mesenchymal cells
relative to epithelial cells as has been noted for bladder epithelial and stromal cells [10]. During
the chase period of 52 days we observed a rapid reduction in the number of BrdU-labeled cells
from Day 10 to Day 28 (13-fold) in iWAT and a slower decline in BAT (3-fold). However, at
Day 52 all fat depots examined showed a low but clearly detectable level of LRC with the
lowest observed in eWAT depot (0.53%).
Analysis of immunohistological samples consistently showed that BrdU-cells were confine to
two regions within fat tissues: the perivascular wall and sparsely arranged among adipocytes
regardless of fat depot or chase time point. Localization of a major group of BrdU-labeled cells
to the perivasculature is consistent with the recent studies on human fat tissues that have
attempted to localize the ASC niche. Traktuev et al. demonstrated that stromal cells of
subcutaneous adipose tissue with properties of ASC serve structurally and functionally as
pericytes [19]. A similar study by Zannettino et al. revealed that multipotential stem cell
populations within human adipose tissues are intimately associated with perivascular cells
[20]. In those studies [19,20], flow cytometric methods were applied to phenotype ASC in
human fat tissues. We detected two different niches of LRC/ASC in mice fat depots with
immunohistochemical and immunofluorescence techniques that are standard methods for the
detection and quantification of molecules of interest in adipocyte tissues [21].
In our second experiment (BrdU labeling of fat depot in adult animals) we used flow cytometry
to quantify and molecularly phenotype BrdU-labeled cells. The analysis showed that 1.7% of
iWAT and 6% of eWAT stromal-vascular fractions of cells are BrdU-positive. These data
correlate well with morphometrically quantified 2.9% of BrdU-labeled cells in retroperitoneal
fat depot collected from mature rats that were given intraperitoneal injection of BrdU [21].
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Earlier studies that used [3H]thymidine labeling showed that populations of cells in stromal-
vascular fractions of adipose tissue can take up this DNA precursor suggesting the presence
of proliferating cells within tissue [2,16]. Hirsh and co-workers in their studies of de novo
production of adipocytes in adult rats used biochemical and radioautographic techniques for
detection of incorporated radiolabeled thymidine into fat DNA [2]. They showed that a small
population of stromal-vascular fraction of epididymal (0.1% of total cells) and retroperitoneal
(0.3% of total cells) fat depots, but not fat cells incorporate [3H]thymidine after IP injection
into adult rats [2]. Although not substantial, discrepancies between Hirsh's and our own data
can be attributed to the distinct methods of labeling followed by different detection assays and/
or differences between species (rats vs. mouse model).
To further characterize LRC we analyzed the expression of stem cell antigen-1 (Sca-1). Sca-1
has been used as a candidate marker in the search for tissue-resident stem cells [22]. Recent
studies have associated Sca-1 antigenicity with adipocyte progenitors in fat depots [23] and
our recent studies suggest that Sca-1 is a biomarker for ear mesenchymal stem cells (EMSC)
that have the potential to become functionally active adipocytes [17]. Present FACS analysis
of BrdU-labeled stromal-vascular fraction cells revealed that more than half of iWAT and
eWAT fractions are Sca-1 positive. Simultaneous analysis of LRC for markers of the
hematopoietic lineage (CD45 and CD4) showed that approximately 70% of inguinal and
epididymal cells are positive. We conclude that LRC in stromal-vascular fractions of fat depots
include the following immunophenotypes: Sca-1+/CD45−/CD4−; Sca-1+/CD45+/CD4+; and
Sca-1−/CD45+/CD4+. Further analyses of the properties of each of these sub-populations are
currently underway in our laboratory.
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Immunohistochemical analysis of BrdU-retaining cells in mouse fat depots. 3.5-day-old male
C57BL6/J mice were administered BrdU for 3 consecutive days. Animals were euthanized at
different time points. BAT—Day 10 (A), Day 28 (B), Day 52 (C); iWAT—Day 10 (D), Day
39 (E), Day 52 (F); eWAT—Day 28 (G), Day 52 (H). (I–K) Mean BrdU label index. Error
bars represent ±SD (*p< 0.05; ***p < 0.001). (L, M) Immunofluorescent detection of BrdU-
labeled cells (green) in 10-day-old C57BL6/J males: (L) BAT and (M) iWAT. Cells nuclei
counterstained with DAPI (blue). Magnification 20×.
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Localization of BrdU-labeled cells within iWAT (A–C) and in white adipocyte tissues
surrounding BAT (D). Immunohistochemically detected BrdU-labeled cells localize to blood
vessels walls (arrows) and among adipocytes (arrowheads). Day chase period: 10 (A), 39 (B),
and 52 (C, D). Magnification 20×; inset in (C) 40×.
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Flow cytometric analysis of BrdU retention and Sca-1 expression in stromal-vascular fraction
of fat depots (A, D, B, and E) and BM (C, F) cells. (A)–(C) Representative flow cytometric
analysis of iWAT (A), eWAT (B), and BM (C) collected from four months old male C57BL6/
J animals treated with BrdU. (D)–(F) Flow cytometry plots from control, saline treated animals
(D) iWAT; (E) eWAT; and (F) BM.
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